close
Add to watchlist
DARA BioSciences Inc (DARA)
DARA BioSciences, Inc., a development-stage pharmaceutical company, acquires promising therapeutic small molecules and develops them through proof of concept in humans for subsequent sale or out-licensing to larger pharmaceutical companies. The company has two drug candidates with cleared IND's (Investigation New Drug) Applications from the U.S. FDA. Its drug development programs include KRN5500, which successfully completed a Phase IIa clinical trial for the treatment of neuropathic pain in cancer patients. DARA BioSciences also has a portfolio of drug candidates for type 2 diabetes and psoriasis. The company is headquartered in Raleigh, North Carolina.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 1.85 |
| Volume | 20061 |
| Volume Avg | 71027 |
| 52 Week High | 3.50 |
| 52 Week Low | 0.88 |
| PE | N/A |
| PE (group average) | N/A |
| EPS Year | -1.20 |
| EPS change Q/Q | -8.33% |
| EPS change Q/Q Yr ago | -31.58% |
| EPS change Q/Q next Q est | 100% |
| EPS change Y/Y | -21.51% |
| REV change Q/Q | 0% |
| REV change Q/Q Yr ago | 0% |
| EPS next Q est | 0.00 |
| EPS next Y est | 0.00 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |